Chemomab Therapeutics Ltd. Stock-Based Compensation
Chemomab Therapeutics Ltd. (CMMB) reported Stock-Based Compensation of $623.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-03-23
- Chemomab Therapeutics Ltd. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $639.00K, a 16.03% decline year-over-year.
- Chemomab Therapeutics Ltd. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $484.00K, a 44.62% decline year-over-year.
- Chemomab Therapeutics Ltd. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $740.00K, a 26.59% decline year-over-year.
- Chemomab Therapeutics Ltd. share-based payment arrangement, noncash expense for the quarter ending 2022-09-30 was $836.00K, a 89.57% increase year-over-year.
- Chemomab Therapeutics Ltd. share-based payment arrangement, noncash expense for fiscal 2020 was $130.00K, a 88.77% decline from fiscal 2019.
- Chemomab Therapeutics Ltd. share-based payment arrangement, noncash expense for fiscal 2019 was $1.16M, a 39.88% decline from fiscal 2018.
- Chemomab Therapeutics Ltd. share-based payment arrangement, noncash expense for fiscal 2018 was $1.93M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $623.00K 20-F · filed 2026-03-23 | |||||||
| 2025-06-30 | $245.00K 6-K · filed 2025-08-14 | |||||||
| 2024-12-31 | $617.00K 20-F · filed 2026-03-23 | |||||||
| 2024-06-30 | $355.00K 6-K · filed 2025-08-14 | |||||||
| 2023-12-31 | $1.49M 20-F · filed 2026-03-23 | |||||||
| 2023-06-30 | $639.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-08-21 | $1.12M 6-K · filed 2024-08-21 | $1.86M derived: sum of 3 quarters · filed 2025-04-04 | $2.70M derived: sum of 4 quarters · filed 2025-04-04 | ||||
| 2023-03-31 | $484.00K 10-Q · filed 2023-05-11 | $1.22M derived: sum of 2 quarters · filed 2025-04-04 | $2.06M derived: sum of 3 quarters · filed 2025-04-04 | $2.82M derived: sum of 4 quarters · filed 2025-04-04 | ||||
| 2022-12-31 | $740.00K derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | $1.58M derived: sum of 2 quarters · filed 2025-04-04 | $2.34M derived: sum of 3 quarters · filed 2025-04-04 | $3.21M 20-F · filed 2025-04-04 | ||||
| 2022-09-30 | $836.00K derived: 10-Q 9 month − 6-K 6 month · filed 2022-11-10 | $1.60M derived: sum of 2 quarters · filed 2023-08-14 | $2.47M 10-Q · filed 2022-11-10 | $3.48M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-06-30 | $761.00K derived: 6-K 6 month − 10-Q 3 month · filed 2023-08-14 | $1.64M 6-K · filed 2023-08-14 | $2.64M derived: sum of 3 quarters · filed 2024-03-28 | $3.08M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-03-31 | $874.00K 10-Q · filed 2023-05-11 | $1.88M derived: sum of 2 quarters · filed 2024-03-28 | $2.32M derived: sum of 3 quarters · filed 2024-03-28 | $2.85M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2021-12-31 | $1.01M derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | $1.45M derived: sum of 2 quarters · filed 2024-03-28 | $1.98M derived: sum of 3 quarters · filed 2024-03-28 | $2.02M 20-F · filed 2024-03-28 | ||||
| 2021-09-30 | $441.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $968.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.01M 10-Q · filed 2022-11-10 | $1.04M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $527.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $570.00K 10-Q · filed 2022-08-12 | $603.00K derived: sum of 3 quarters · filed 2022-08-12 | $626.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $43.00K 10-Q · filed 2022-05-12 | $76.00K derived: sum of 2 quarters · filed 2022-05-12 | $99.00K derived: sum of 3 quarters · filed 2022-05-12 | $127.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $56.00K derived: sum of 2 quarters · filed 2022-03-30 | $84.00K derived: sum of 3 quarters · filed 2022-03-30 | $130.00K 10-K · filed 2022-03-30 | -$20.00K 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $51.00K derived: sum of 2 quarters · filed 2021-11-12 | $97.00K 10-Q · filed 2021-11-12 | -$93.00K 10-Q · filed 2020-11-16 | $186.00K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $74.00K 10-Q · filed 2021-08-13 | $264.00K 10-Q · filed 2020-08-14 | $163.00K derived: sum of 3 quarters · filed 2021-08-13 | $484.00K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $46.00K 10-Q · filed 2021-05-13 | $186.00K 10-Q · filed 2020-05-07 | $135.00K derived: sum of 2 quarters · filed 2021-05-13 | $456.00K derived: sum of 3 quarters · filed 2021-05-13 | $824.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $410.00K derived: sum of 2 quarters · filed 2021-03-09 | $778.00K derived: sum of 3 quarters · filed 2021-03-09 | $1.16M 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | $321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $689.00K derived: sum of 2 quarters · filed 2020-11-16 | $1.07M 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | $368.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $748.00K 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | $380.00K 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $1.93M 10-K · filed 2020-03-17 |